Translating genomics to improved patient care
The search for better treatments has gained new impetus with the discovery of PCSK9 (proprotein convertase subtilisin/kexin type 9).
PCSK9 offers the real possibility for improved management of high-risk patients.
We are at the dawn of the PCSK9 revolution.
videoDownload the slideset